Reblog: 13 Simple Rules for Better Investing


The fund industry has grown massively in the last 25 years, and it has changed to a better-run, more professional, and lower-cost business, Here are some key lessons for investors:

  1. Build a plan for multiple investment goals and stick to it.
  2. Align your investments with each goal.
  3. Keep costs low, but evaluate whether some services like paying for financial or tax advice are worth the price if you don’t have the time or investing acumen to do it yourself.
  4. Choose funds that are good bets for five years from now because they have the depth of managers and analysts, low costs, and strong stew­ardship to keep them on the right path.
    Continue Reading →

stockarchitect February 28, 2018

Equity / Fixed Income / Funds / Goals / Investing / Investment / morningstar.co.uk / Rules / Russel Kinnel /

Reblog: The Stock Market Is Only As Smart As the Investors Who Comprise It


A Buy and Hold friend of mine recently posted the following words to the discussion thread for one of my blog entries: “You’re confusing high valuations (a fact, historically speaking) with overvaluations (a judgement that the market is wrong, in effect that you’re smarter than Wall Street).

I like the comment because it concisely and clearly reveals the primary difference between Buy and Hold believers and Valuation-Informed Indexers. It is absolutely correct to say that I believe that the market is wrong. That’s the entire idea of Valuation-Informed Indexing. We can know when the market is getting things wrong and how off the mark the market is and we should put that knowledge to good use by adjusting our stock allocations accordingly.

My Buy and Hold friend dismisses out of hand the possibility that the market has gotten things wrong. His comment suggests that the market is comprised largely of Wall Street experts who possess more knowledge about the value of stocks than I possess. So I should just give up this effort to outsmart the market.

Continue Reading →

stockarchitect February 26, 2018

Buy / Hold / Rob Bennett / Smart Investors / valuewalk.com / Wall Street /

Reblog: H G Infra Engineering Ltd. IPO Review


H G Infra Engineering Ltd. (HGIEL) is an infrastructure construction, development and management company with extensive experience in focus area of road projects, including highways, bridges and flyovers. Its main business operations include (i) providing engineering, procurement and construction (“EPC”) services on a fixed-sum turnkey basis and (ii) undertaking civil construction and related infrastructure projects on item rate and lump sum basis, primarily in the roads and highway sector. It has also forayed into executing water pipeline projects and is currently undertaking two water supply projects in Rajasthan on a turnkey basis which includes the designing, construction, operation and maintenance of the project. HGIEL enjoys accreditations, such as the ISO 9001:2015, ISO 14001:2004, OHSAS 18001:2007 certification for quality management systems, environment management systems, and health and safety management systems, respectively, issued by LMS Assessment Services Private Limited.

HGIEL has executed or is executing projects across various states in India covering Rajasthan, Uttar Pradesh Haryana, Uttarakhand, Maharashtra and Arunachal Pradesh. During the last five years, Company has completed 13 projects above the contract value of Rs. 40 crore in the roads and highways sector aggregating to a total contract value of Rs. 1674.89 crore, which included construction, improving, widening, strengthening of two and four lane highways, construction of high-level bridge and construction of earthen embankment, culverts and cart track underpasses. As on November 30, 2017, Company has 21 ongoing projects in the roads and highways sector which includes construction, improving, widening, strengthening, up gradation and rehabilitation of two, four and six-lane highways construction of high-level bridge and construction of road network. HGIEL’s order book for these ongoing projects in the roads and highways sector amounted to Rs. 3585.31 crore as on November 30, 2017, accounting for 96.70% of its total Order Book. As of November 30, 2017, it had a total Order Book of Rs. 3707.81 crore, consisting of 21 projects in the roads and highways sector, four civil construction projects and two water supply projects.

Continue Reading →

stockarchitect February 26, 2018

Chittorgarh.com / Dilip Davda / H G Infra / IPO / IPO review /

Sensex rises 323 pts, Nifty closes at 10491; Metal, Pharma stocks rally


The domestic indices ended 1% higher on Friday taking cues from the global markets. The S&P BSE Sensex ended at 34,142, up 323 points while the broader Nifty50 index settled at 10,491, up 108 points.

Among sectoral indices, the Nifty Metal index ended nearly 3% higher on Friday led by a rise in the shares of Jindal Steel & Power, Tata Steel and National Aluminium Company. The Nifty Pharma index also ended over 2.5% higher led by surge in the stocks of Sun Pharmaceutical Industries and Divi’s Laboratories.

Sun Pharmaceutical Industries turned volatile, trading 3.5% higher at Rs 561 on the BSE at 02:34 pm on Friday, after the company said the US Food and Drug Administration (USFDA) issued Form 483, with three observations, for its Halol facility in Gujarat.

Continue Reading →

stockarchitect February 24, 2018

arjunmody01 / bmawealth / Bosch / brahmachary / HCL Tech / jateenkr / KJsimply / SAIL / Shriram Transport Finance / Steel Authority / Yes Bank /

Reblog: How to Master TradingView in Less than 20 minutes


TradingView charting platform has a ton of features that you can take advantage of.

You’ve got indicators, tools, watchlist, templates, chat, charts, ideas, scripts, and etc.

But the problem is:

You’d have to spend many hours trying to figure out how things work, and decide which features are relevant to you.

So…

Won’t it be great if you can learn how to use the most important tools that TradingView offers — without getting distracted?

Continue Reading →

stockarchitect February 21, 2018

Chart Reading / charts / Rayner / Tips / Tradingview / Tricks / tutorial / www.tradingwithrayner.com /

Reblog: Stop Loss – Advantages and Disadvantages


Stop loss is one of the three fundamental parts in trading ( the other two are take profit and entry). The subject of Stop Loss (SL) is very important and interesting to discuss thus this article! I would like to go over some of the advantages and disadvantages of using a stop loss as opposed to trading without one. I would love to hear your opinion on the subject below in the comment section – thank you!

So let’s begin:

First of all: An advantage for one trader could be a disadvantage for another one! Remember that, it is all strictly individual and you must find your way and what it works for you. There is no reason why two traders, one who uses SL and one who doesn’t, won’t make money at the same time.

Continue Reading →

stockarchitect February 19, 2018

Advantage / Disadvantage / Leverage / Profit / Stop Loss / trader / Trailing Stop /

Closing Bell Friday: Sensex falls 287 pts, Nifty ends below 10,500; PSU Bank Index dips 2.5%


The benchmark indices ended off day’s low but remained under pressure during the day.

The 30-share BSE Sensex was down 286.71 points at 34,010.76 and the 50-share NSE Nifty was down 94.30 points at 10,451.20.

The PSU Bank index fell more than 2.5% as all stocks caught in a bear trap after PNB detected transaction fraud worth USD 1.8 billion (Rs 11,300 crore). PNB and Bank of Baroda were biggest losers, falling nearly 5 percent each. Bank of India, IDBI Bank, Union Bank, Syndicate Bank, SBI, Indian Bank, Canara Bank, Andhra Bank, OBC and Allahabad Bank were down 1-3 percent.

Fortis Healthcare slipped 20% to Rs 115 in noon deal trade, falling 24% from its intra-day high on BSE on back of heavy volumes after the Supreme Court (SC) allowed financial institutions to sell pledged shares of the company.

Continue Reading →

stockarchitect February 17, 2018

Avanti Feeds / Bank of India / Bbrijesh / FinSec_com / Hindalco / marketcalls_ / Pacefin / PNB / Punjab National Bank / Tata Communications / TV_TradingIdeas /

Reblog: Why I Ditched Technical Indicators (And Why You Should Too)


While the article talks about Forex, the underlying concept applies to stocks as well.

technical-indicators

Technical indicators are no doubt a favorite topic in the financial markets. They can range from a simple moving average to a complex array of algorithms.

It doesn’t matter whether you’re trading stocks, commodities, futures or any other market; technical indicators are a common theme.

Useful? Well, that’s another matter entirely.

But of all the financial markets, Forex is arguably the worst offender of overutilizing indicators. Proprietary languages like MetaTrader’s MQL have made it relatively easy for newcomers to design anything imaginable.

Other trading platforms offer similar languages. There are even businesses that do nothing but custom code indicators for clients.

And if you ask me, it’s closer to being part of the problem than the solution.

Continue Reading →

stockarchitect February 14, 2018

dailypriceaction.com / Justin Bennett / Technical / trader / Trading /

Reblog: How To Use The Reward Risk Ratio Like A Professional


The reward to risk ratio (RRR, or reward:risk ratio) is maybe the most important metric in trading and a trader who understands the RRR can improve his chances of becoming profitable.

A trader who uses the RRR incorrectly will never become profitable on the other hand. In this article, I will show you what you need to know about the RRR.

Busting myths around the reward:risk ratio

Let’s first tackle some of the common misconceptions about the RRR to help you understand what most people get wrong before then diving into the specifics of the RRR.

Myth 1: The reward:risk ratio is useless

You often read that traders say the reward-risk ratio is useless which couldn’t be further from the truth. When you use the RRR in combination with other trading metrics (such as winrate), it quickly becomes one of the most powerful trading tools.

Without knowing the reward:risk ratio of a single trade, it is literally impossible to trade profitably and you’ll soon learn why.

Continue Reading →

stockarchitect February 12, 2018

Risk Management / risk reward ratio / Statistics / Tradeceity / trader / Trading /

Reblog: Aster DM Healthcare IPO Review


Aster DM Healthcare Ltd. (Aster) is one of the largest private healthcare service providers which operate in multiple GCC states based on the number of hospitals and clinics and an emerging healthcare player in India. GCC states that comprise the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain. It also operates in Jordan and Philippines. Aster is having operations in different verticals and geographies. It has already started work for 10 new hospitals, 5 in GCC states and 5 in India. Although it has a larger portion of revenues coming from GCC states, due to India based company, it has registered office in the southern region and is mulling listing in India. Asters hospitals in India are located in Kochi, Kolhapur, Kottakkal, Bengaluru, Vijaywada, Guntur, Wayanad and Hyderabad. These are operated under “Aster”, “MIMS”, “Ramesh” or “Prime”, “Aster Aaadhar” and “Aster CMI” brands. Its clinics are located at Kozhikode, Eluru and Bengaluru. As of 30.09.17 the company had 17408 employees including 1417 full-time doctors, 5797 nurses, 1752 paramedics and 8442 other employees. In addition, it had 891 “fee for service” doctors.  Aster has a diversified portfolio of healthcare facilities, consisting of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017. Overall currently it has total 323 operating facilities.

Majority of Aster hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, pediatrics, gastroenterology, orthopedics and critical care services. Aster had plans on the table for more large hospitals in metros of India before the budget, but now it mulls affordable hospitals in tier –II and tier- III cities and in rural areas. No plans have been firmed up so far in this regard.

Continue Reading →

stockarchitect February 12, 2018

Aster DM Healthcare / Chittorgarh.com / Dilip Davda / IPO / IPO review /

1 … 56 57 58 59 60 … 90